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ABSTRACT 
 
Purpose: Posterior Capsule Opacification (PCO) is a vision impairing disease 
that occurs in some adults and most children following cataract surgery. In 
fibrotic PCO, myofibroblasts migrate onto the posterior capsule and contract to 
produce wrinkles that affect visual acuity. Myofibroblasts are derived from 
Myo/Nog cells that express the skeletal muscle transcription factor MyoD, the 
BMP inhibitor Noggin and the G8 protein. Ex vivo depletion of Myo/Nog cells in 
human lens tissue had been achieved by incubating explants with the G8 
monoclonal antibody (mAb) and complement. The goal of this study was to test 
the specificity and efficacy of the G8 mAb complexed to 3DNA nanocarriers 
intercalated with Doxorubicin (G8-3DNA-Dox) in explants of human lens tissue 
and rabbits undergoing cataract surgery. 
 
Methods: Anterior human lens tissue obtained by capsulorhexis was cultured in 
serum free medium. Lens explants were incubated with G8-3DNA-Dox, G8-3DNA 
or 3DNA-Dox. Explants were assayed for apoptosis using TUNEL. Rabbits were 
injected at the time of cataract surgery with either balanced salt solution (BSS) 
or G8-3DNA-Dox at doses of 7.0 or 70ug/ml. The rabbits were observed for a 
period of four weeks for the development of adverse reactions, including PCO. 
 
Results: G8-3DNA-Dox specifically targeted and induced apoptosis in Myo/Nog 
cells in human lens tissue. Control conjugates did not affect Myo/Nog or lens 
epithelial cells. G8-3DNA-Dox also targeted Myo/Nog cells in the lens of rabbits 
that underwent cataract surgery. Slit lamp, gross exam and histopathology 
analyses revealed that rabbits injected with 70ug/ml of G8-3DNA-Dox had 
mostly clear posterior capsules with scant areas of PCO without fibrosis. 
Control rabbits injected with BSS or 7.0ug/ml G8-3DNA-Dox developed 
extensive PCO and fibrosis 
 
Conclusions: Antibody-3DNA nanocarriers are highly specific reagents for 
delivering cytotoxic cargo to a subpopulation of cells. The 3DNA nanocarriers 
themselves are nontoxic. Administration of G8-3DNA-Dox at the time of cataract 
surgery may reduce the incidence of PCO and maintain vision. 
 
 INTRODUCTION    
                                                                                                         
3DNA nanocarriers are branched structures built from interconnected 
monomers of natural or synthetic DNA. The 3DNA monomers are composed of 
two DNA strands hybridized together  with a double stranded “waist” and four 
single-stranded “arms”. 3DNA is layered by successive annealing of monomer 
arms. The typical 2-layer 3DNA has a diameter of approximately 70nm and 
consists of approximately 4,000 bases with 36 single stranded arms. A variety 
of molecules may be attached to the arms, including fluorescent reporters, 
siRNAs, peptides and antibodies. Cytotoxic cargo, such as the anthracycline 
antibiotic Doxorubicin, can be intercalated into the double-stranded regions of 
the 3DNA. 
 
The purpose of this study was to test an antibody-3DNA-Doxorubicin 
conjugate for specificity and toxicity in vitro and in vivo. The targeting 
monoclonal antibody, called G8, recognizes a cell surface molecule on Myo/Nog 
cells, so named for their expression of the skeletal muscle specific transcription 
factor MyoD and the bone morphogenetic protein inhibitor Noggin (Gerhart et al 
2006). Myo/Nog cells are widely distributed in the embryo and in normal and 
diseased tissues of the adult (Gerhart et al 2001, 2008, 2009, 2012; Walker et al 
2010). Myo/Nog cells are present in the anterior and equatorial regions of the 
human lens, the cornea and ciliary body (Gerhart et al 2014).  In addition to their 
role as regulators of BMP signaling, Myo/Nog cells develop into myofibroblasts 
in response to injury (Gerhart et al 2008, 2011, 2012, 2014; Walker et al 2010).  
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  Targeted Delivery of Cytotoxic Cargo   
A. Schematic representation of the G8 IgM mAb coupled to a 2-layer 3DNA nanocarrier 
intercalated with Doxorubicin (G8-3DNA-DOX).  
B. Proposed mechanism of targeted cytotoxicity: Doxorubicin diffuses from 3DNA following 
antibody binding and internalization of the conjugate into acidic compartments of the cell.  
C-E. Anterior  lens tissue was incubated with Lysosensor dye that fluoresces green at an 
acidic pH and G8-3DNA-Cy3 (red) for 2 hours. Co-localization of red and green appears 
yellow in the merged image in E. Nuclei were labeled with Hoechst dye (blue).  The cell 
indicated with the arrows is enlarged in E. 
 
G8 mAb coupled to 3DNA is internalized into acidic compartments of the 
cell. 
Distribution of Myo/Nog Cells in Human Anterior Lens Tissue  
Removed During Cataract Surgery 
 
Anterior lens tissue fixed directly after capsulorhexis was double labeled with the G8 mAb 
and antibodies to Noggin (NOG), MyoD protein (MyoDp), alpha smooth muscle actin (α-
SMA),  Vimentin (VM), the skeletal muscle specific 12101 antigen (12101), sarcomeric 
myosin heavy chain (MYOSIN), and troponin T (TPNT). Tissue  incubated with secondary 
antibodies alone, lacked fluorescence (I-J).  
 
Myo/Nog cells were present in low numbers throughout the lens epithelium.    
Myo/Nog cells were concentrated around areas of the capsule denuded of 
epithelial cells.   
 
Some Myo/Nog cells had migrated onto the capsule (arrows in B).  
MyoNog cells express α-sma and skeletal muscle proteins in the anterior 
lens.  
Wrinkles appeared in the capsule in some areas surrounded by Myo/Nog 
cells (arrowheads in D and H).  
(Gerhart et al 2014) 
SUMMARY AND CONCLUSIONS 
 
Myo/Nog cells are present in the anterior and equatorial regions of the human 
lens.  
 
In anterior lens tissue removed during cataract surgery, Myo/Nog cells are 
enriched around cell free areas of the capsule.  Some areas surrounded by 
Myo/Nog cells contain a wrinkle in the capsule, suggesting that Myo/Nog cells 
may be contractile.   
 
3DNA nanocarriers are novel reagents for delivering cytotoxic cargo to cells. 
 
3DNA nanocarriers can be bound with antibodies or other molecules to 
specifically target a subpopulation of cells. 
 
Treatment of anterior lens tissue in vitro and rabbit lenses in vivo with 
G8-3DNA-DOX  specifically targets and kills Myo/Nog cells. 
 
Injection of G8-3DNA-DOX into the rabbit lens at the time of cataract surgery 
reduced PCO.   
 
Depleting Myo/Nog cells during cataract surgery may decrease the incidence of 
lens re-opacification and capsular wrinkling caused by myofibroblast-like cells.  
Depleting Myo/Nog Cells in Anterior Lens Tissue  
with G8-3DNA-DOX 
 
Anterior lenses were incubated with the G8-3DNA-Dox or 3DNA-DOX (Control) for 
24 hours after plating.  Lenses were fixed and screened for G8 expression and 
apoptosis using TUNEL reagents. TUNEL positive cells are red and G8 positive 
cells are green. Overlap of red and green appears yellow (A-F).  Some lenses were 
incubated for 5 days with G8-3DNA-DOX, or with the control reagents 3DNA-DOX 
and G8-3DNA (G-I).  Lenses were fixed and screened for G8 (red) and α−SMA 
(green).   
 
Treatment with the G8-3DNA-DOX specifically targets and kills 
Myo/Nog cells.   
 
No G8 positive or α−SMA cells were observed in the lenses treated 
with G8-3DNA-Dox. 
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  Depleting Myo/Nog Cells In Vivo  
Rabbits were injected with either balanced salt solution (BSS) or G8-3DNA-Dox at doses of 
7.0 or 70ug/ml following capsulorhexis and phacoemulsion. The rabbits were observed for a 
period of four weeks for the development of adverse reactions, including PCO.  A few 
animals were culled after 24 hours and screened for G8 expression and apoptosis using 
TUNEL reagents. TUNEL positive cells are red and G8 positive cells are green. Overlap of 
red and green appears yellow  (A-D). After 4 weeks the remaining animals were culled and 
the globes were examined for the presence of PCO (I-L).  Tissue sections were screened for 
G8 (red) and α−SMA (green), (E-H).   
  
Treatment with the G8-3DNA-DOX at 70ug/ml specifically targets and kills 
Myo/Nog cells.   
 
The number of α−SMA positive cells is reduced in lenses treated with G8-
3DNA-DOX at 70ug/ml.  
 
Treatment with the G8-3DNA-DOX at 70ug/ml reduces PCO. 
Treatment Central PCO Peripheral PCO Soemmering’s Ring 
Intensity 
Balanced Salt Solution 2.16 +/-1.32 2.66 +/-1.17 5.9 +/-1.42 
G8-3DNA-Dox 
7.0ug/ml 
1.5 +/-0.8 2.16+/-0.76 5.33 +/-1.15 
G8-3DNA-Dox 
70.0ug/ml 
0.62 +/-0.47 1.12 +/-0.62 4 +/-1.41 
G8-3DNA-Dox 
Hydrogel 70.0ug/ml 
0.5 +/-0 0.66 +/-0.28 2.66 +/-1.15 
G8-3DNA-Dox 
IOL Presoak 
70.0ug/ml 
0.5 +/-0.5 
 
1.16 +/-0.76 4.66 +/-2.30 
Quantification of PCO Following Injection of G8-3DNA-Dox During Cataract 
Surgery 
 
Following phacoemulsion, rabbit lenses were injected with BSS, 7ug or 70ug G8-3DNA-Dox, or 
70ug G8-3DNA-Dox in a hydrogel. Some animals were injected with 70ug G8-3DNA-Dox plus the 
intraocular lens was soaked in 70ug G8-3DNA-Dox prior to implantation. Four weeks post 
surgery the animals were culled and their globes were assessed for severity of PCO and 
Soemmering’s ring formation using methods established in the laboratory at the Intermountain 
Ocular Research Center (Werner  L, Mamalis N, et al 2005). 
  
Treatment with the G8-3DNA-DOX at 70ug/ml reduces central and peripheral PCO 
and the intensity of  Soemmering’s ring. 
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